Fibrin stimulates platelets to increase factor VIIIa binding site expression

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 10, 2004, Pages 1806-1815

  Phillips, J E ^a,c,d   Lord, S T ^b   Gilbert, Gary E ^a,c,d  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Factor VIII; Fibrin; GPIIbIIIa; Platelets

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8A; FIBRIN; FIBRINOGEN; FIBRINOGEN RECEPTOR; FLUORESCEIN; HEMOGLOBIN GAMMA CHAIN; MUTANT PROTEIN; PROCOAGULANT; PROTEIN INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FIBRIN POLYMERIZATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOGENESIS; THROMBUS; UPREGULATION;

BINDING SITES; BLOOD PLATELETS; FACTOR VIIIA; FIBRIN; FLOW CYTOMETRY; HUMANS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBIN; UP-REGULATION;

EID: 13244260727     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00919.x     Document Type: Article

References (45)

1. van Dieijen G, Tans G, Rosing J, Hemker H. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-42.
2. Gilbert GE, Arena AA. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine. J Biol Chem 1996; 271: 11120-5.
3. Rawala-Sheikh R, Ahmad S, Ashby B, Walsh P. Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 1990; 29: 2606-11.
4. Rosing J, van Rijn J, Bevers E, van Dieijen G, Comfurius P, Zwaal R. The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65: 319-32.
5. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 1381-9.
6. 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem 1988; 263 16467-70.
7. Rosing J, Bevers E, Comfurius P, Hemker H, van Dieijin G, Weiss H, Zwaal R. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood 1985; 65: 1557-61.
8. Bevers E, Comfurius P, Zwaal R. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66.
9. Chang CP, Zhao J, Wiedmer T, Sims PJ. Contribution of platelet microparticle formation and granule secretion to the transbilayer migration of phosphatidylserine. J Biol Chem 1993; 268: 7171-8.
10. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991; 266: 17261-8.
11. 2+-ATPase inhibitors. Biochemistry 1995; 34: 11625-34.
12. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 1992; 79: 380-8.
13. Gilbert GE, Arena AA. Phosphatidylethanolamine induces high affinity binding sites for factor VIII on membranes containing phosphatidyl-L-serine. J Biol Chem 1995; 270: 18500-5.
14. Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody; potential implications for the effect of c7E3 Fab treatment on acute thrombosis and 'clinical restenosis'. J Clin Invest 1996; 98: 863-74.
15. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1988.
16. Gilbert GE, Drinkwater D, Barter S, Clouse SB. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII: studies with model membranes supported by glass microspheres (Lipospheres). J Biol Chem 1992; 267: 15861-8.
17. Binnie CG, Hettasch JM, Strickland E, Lord ST. Characterization of purified recombinant fibrinogen. partial phosphorylation of fibrino-peptide A. Biochemistry 1993; 32: 107-13.
18. Rooney MM, Parise LV, Lord ST. Dissecting clot retraction and platelet aggregation: clot retraction does not require an intact fibrinogen gamma chain C terminus. J Biol Chem 1996; 271: 8553-5.
19. Rooney MM, Farrell DH, van Hemel BM, de Groot PG, Lord ST. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. Blood 1998; 92 (7): 2374-81.
20. Ahmad SS, Scandura JM, Walsh PN. Structural and functional characterization of platelet receptor-mediated factor VIII binding. J Biol Chem 2000; 275: 13071-81.
21. Williamson P, Bevers EM, Smeets EF, Comfurius P, Schlegel RA, Zwaal RFA. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 1995; 34: 10448-55.
22. Smeets EF, Heemskerk JWM, Comfurius P, Bevers EM, Zwaal RFA. Thapsigargin amplifies the platelet procoagulant response caused by thrombin. Thromb Haemost 1993; 70: 1024-9.
23. Smeets EF, Comfurius P, Bevers EM, Zwaal RF. Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim Biophys Acta 1994; 1195: 281-6.
24. Saenko EL, Scandella D, Yakhyaev AV, Greco NJ. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets. J Biol Chem 1998; 273: 27918-26.
25. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane: studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-57.
26. Dachary-Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-65.
27. Niewiarowski S, Holt JC, Cook JJ. Biochemistry and physiology of secreted platelet proteins. In: Colman, RW, Hirsh, J, Marder, VJ, Salzman, EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd edn. J.B, Lippincott Co, Philadelphia, 1994: 546-56.
28. Laudano AP, Doolittle RF. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization: structural requirements, number of binding sites, and species differences. Biochemistry 1980; 19: 1013-9.
29. Plow EF, Marguerie G. Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline. Proc Natl Acad Sci USA 1982; 79: 3711-5.
30. Okumura N, Gorkun OV, Lord ST. Severely impaired polymerization of recombinant fibrinogen gamma-364 Asp → His, the substitution discovered in a heterozygous individual. J Biol Chem 1997; 272: 29596-601.
31. Ahmad SS, Rawala-Sheikh R, Ashby B, Walsh PN. Platelet receptor-mediated factor X activation by factor IXa: high-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome. J Clin Invest 1989; 84: 824-8.
32. Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid binding sites. Blood 2003; 101: 2628-36.
33. Curtis JE, Helgerson SL, Parker ET, Lollar P. Isolation and characterization of Thrombin-Activated human factor VIII. J Biol Chem 1994; 269: 6246-51.
34. Sheehan JP, Phan TM. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism. Biochemistry 2001; 40: 4980-9.
35. McMullen BA, Fujikawa K, Davie EW, Hedner U, Ezban M. Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A). Protein Sci 1995; 4: 740-6.
36. Koszelak ME, Huggins CF, Fay PJ. Sites in the A2 subunit involved in the interfactor VIIIa interaction. J Biol Chem 2000; 275: 27137-44.
37. Charo IF, Kieffer N, Phillips DR. Platelet membrane glycoproteins. In: Colman, RW, Hirsh, J, Marder, VJ, Salzman, EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. J.B. Lippincott Co, Philadelphia, 1994: 489-507.
38. Hantgan RR. Localization of the domains of fibrin involved in binding to platelets. Biochim Biophys Acta 1988; 968: 36-44.
39. Hantgan RR. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism. Biochim Biophys Acta 1988; 968: 24-35.
40. 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992; 267: 11300-6.
41. Haimovich B, Lipfert L, Brugge IS, Shattil SJ. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J Biol Chem 1993; 268: 15868-77.
42. Huang MM, Lipfert L, Cunningham M, Brugge JS, Ginsberg MH, Shattil SJ. Adhesive figand binding to integrin alpha (IIb) beta (3) stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp 125 (FAK). J Cell Biol 1993; 122: 473-83.
43. Cierniewski CS, Byzova T, Papierak M, Haas TA, Niewiarowska J, Zhang L, Cieslak M, Plow EF. Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses. J Biol Chem 1999; 274: 16923-32.
44. Soslau G, Class R, Morgan DA, Foster C, Lord ST, Marchese P, Zuggeri ZM. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001; 276: 21173-83.
45. Nesheim M, Pittman D, Giles A, Fass D, Wang J, Slonosky D, Kaufman RJ. The effect of plasma von willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem 1991; 266: 17815-20.